FDA approves new drug to protect infants, toddlers from RSV

WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.

RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.

The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.

The full article is available at ozarksfirst.com.

MORE NEWS

Weather on KCAX Branson 4U

Ways To Listen to KCAX Branson 4U

We Are Hiring - Smart & Simple Communications